@article{bc1bed8e64b34a71866cfd283bb3d242,
title = "Bing–Neel Syndrome: Update on Diagnosis and Treatment",
abstract = "Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenstr{\"o}m macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients diagnosed with BNS. It is anticipated that further development of Bruton Tyrosine Kinase (BTK) inhibitors and less toxic chemoimmunotherapies will improve treatment delivery and response.",
keywords = "BTK inhibitors, Bing–Neel syndrome, Waldenstr{\"o}m macroglobulinaemia, central nervous system involvement, ibrutinib, lymphoplasmacytic lymphoma, orbital involvement",
author = "Wong, {Evangeline Y.} and Shirley D{\textquoteright}Sa and Minnema, {Monique C.} and Castillo, {Jorge J.} and Dipti Talaulikar",
note = "Publisher Copyright: {\textcopyright} 2022 by the authors.",
year = "2022",
month = dec,
doi = "10.3390/hemato3040051",
language = "English",
volume = "3",
pages = "758--770",
journal = "Hemato",
issn = "2673-6357",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",
}